
Mark Damante, MD retweeted
William Hunt was the Ohio State neurosurgeon who invented the Hunt-Hess grading scale for ruptured aneurysms/SAH & defined Tolosa-Hunt syndrome (painful inflammation of cavernous sinus). Honored to be the Hunt Visiting Professor at @NeurosurgeryOSU, and thrilled to see @BarrowNeuro graduates thriving here…
Mark Damante, MD retweeted
Join us in celebrating Russell R. Lonser, a CNS Past President, as our #2026CNS Founder’s Laurel Award recipient! One of the CNS’s highest honors, this award recognizing exceptional service, lifelong dedication, and meritorious accomplishments in medical education. Lonser’s longstanding leadership and commitment to advancing neurosurgical education exemplify the spirit of this award. Read more: bit.ly/4rHO7jW
#CNSEvolution #neurosurgery
@OSUWexMed
Mark Damante, MD retweeted
Friday was my last OR day @OSUWexMed @NeurosurgeryOSU *more emotional than I expected. I’m grateful for every patient who trusted us and for the colleagues who stood beside me through thousands of cases > 16y. I’ll carry this team and what we built together into my next chapter. – at Columbus, OH
Mark Damante, MD retweeted
A retrospective consortium study on targeted therapies for BRAF V600E mutant papillary craniopharyngioma showed that radiation-sparing, mono-therapeutic, and prolonged treatments are feasible. Read more at:link.springer.com/article/10…
Mark Damante, MD retweeted
Is age prognostic for lower grade IDH mutant glioma?
NO, according to this pooled analysis
In molecular era age alone should not influence decision-making adjuvant treatment
Age is surrogate for IDH status ascopubs.org/doi/10.1200/JCO…
Six abstracts with two podiums @CNS_Update from the @NeurosurgeryOSU tumor and skull base research groups! All possible because of the great work from @MatthieuDWeber (MS4) and #RyanJuncker (MS2), and in collaboration with the @BarrowNeuro RAPID Consortium.
Mark Damante, MD retweeted
🧬Exciting work happening to advance more precise and reproducible delivery of gene therapies to the brain. 🧠
#genetherapy
New in @NeurosurgeryCNS: A systematic, image-guided method for convection-enhanced delivery of gene therapy to the bilateral thalami. Using intraoperative MR-imaging in patients with frontotemporal dementia across 3 international centers, the protocol produced consistent, reproducible thalamic coverage (Vd:Vi linear, R²=0.96). Standardizing the technique flattens the learning curve and drives scalability for deep brain gene therapy.
@NeurosurgeryOSU @OSUWexMed @OSUGeneTherapy @AviadoBio
#Neurosurgery #GeneTherapy #FTD #CED #Neuroscience
ovid.com/10.1227/ons.0000000…
Mark Damante, MD retweeted
New in @NeurosurgeryCNS: A systematic, image-guided method for convection-enhanced delivery of gene therapy to the bilateral thalami. Using intraoperative MR-imaging in patients with frontotemporal dementia across 3 international centers, the protocol produced consistent, reproducible thalamic coverage (Vd:Vi linear, R²=0.96). Standardizing the technique flattens the learning curve and drives scalability for deep brain gene therapy.
@NeurosurgeryOSU @OSUWexMed @OSUGeneTherapy @AviadoBio
#Neurosurgery #GeneTherapy #FTD #CED #Neuroscience
ovid.com/10.1227/ons.0000000…
Surgery for motor metastases pose functional risk that must be weighed against oncologic benefit. Resection preserved or improved function in the majority. Hemorrhage limited recovery, and both hemorrhage and persistent deficits predicted worse survival. ovid.com/jnls/neurosurgery/f…
Mark Damante, MD retweeted
Outstanding collaborative work published in Neurosurgery! Resection of motor gyrus metastases can improve neurological outcomes and survival, highlighting the importance of preserving and restoring function throughout the postoperative course. DOI: 10.1227/neu.0000000000004167
Mark Damante, MD retweeted
🧬 New publication in the Journal of Neurosurgery highlighting advances in CT-guided robotic delivery approaches for targeted brain therapeutics.
Congratulations to @MarkD_Jr and colleagues on this work:
go.osu.edu/DHry
#GeneTherapy #Neurosurgery #Robotics
Mark Damante, MD retweeted
A promising new drug therapy developed by #OSUWexMed neurosurgeon Dr. Shahid Nimjee may hold the key to providing effective treatment to stroke victims and solving one of the biggest complications in strokes: bleeding. health.osu.edu/discovery-and…
Mark Damante, MD retweeted
Just out in @TheJNS from Mark Damante, MD, (@MarkD_Jr ) and @NeurosurgeryOSU. CT-guided cranial #robotics were used to place multiple bilateral convective delivery cannulas in less than 30 min with sub-mm accuracy. This technique can be applied to a wide variety of convective perfusion therapies, including gene therapy.
#Neurosurgery #CED #imaging #genetherapy
thejns.org/view/journals/j-n…
@OhioStateMed @OSUWexMed
Mark Damante, MD retweeted
⚽️ Great way to wrap up the Gene Therapy Symposium – Columbus Crew match with an incredible group.
We’re already looking forward to next year.
#GeneTherapy
Mark Damante, MD retweeted
🧬 Today’s the day.
The 2nd Annual Gene Therapy Symposiumbegins this morning in Columbus.
We’re excited to welcome researchers, clinicians, and industry leaders for two days of discussion, collaboration, and innovation in gene therapy.
#GeneTherapy #GenomicMedicine
Mark Damante, MD retweeted
Honored to have OSU neurosurgery alumnus, Dr. Peruzzi from @BWHNeurosurgery @harvardmed, as our visiting professor for our annual John McGregor, MD lectureship!
Great talk today by Dr. Brad Elder (@NeurosurgeryOSU) on CNS drug delivery, advantages of convective delivery of therapeutics, lessons learned from past clinical trials and exciting new trials using convective delivery for glioma.
Mark Damante, MD retweeted
🧬Program Highlight
Columbus is emerging as a hub for #genetherapy innovation. At the 2nd Annual Gene Therapy Symposium, leaders from across academia, industry, and investment will discuss: "How Gene Therapy is Shaping the Biotech and Innovation Landscape in Columbus."

































